Astrocytes play many roles crucial to normal brain function. For example, astrocytes help to maintain homeostasis in the extracellular fluid (1), modulate neuro nal excitability and synaptic transmission (2, 3), pro vide trophic support for neurons (4, 5) and protect neu rons from oxidative stress (6). Furthermore, astrocyte processes guide migrating neurons and direct axonal growth during development (7, 8) . Thus, the studies on the regulation and maintenance of astrocyte morphology are important for understanding brain development.
When cultured astrocytes are treated with agents that elevate intracellular cyclic AMP, they become process bearing stellate cells and resemble differentiated astro cytes in vivo (9-12). The cyclic AMP-mediated stellation of cultured astrocytes has been widely used as a model for studying astrocyte differentiation. However, very little is known about developmental changes of the mechanisms regulating astrocyte stellation. Therefore, in the present study, we used cultured astrocytes obtained from em bryonic and postnatal rat brain and investigated possible developmental changes of astrocyte stellation induced by ~-adrenoceptor stimulation. Such data will provide useful information about the factors regulating astrocyte differentiation.
MATERIALS AND METHODS

Cell culture
Astrocyte cultures were prepared from the cerebral cortices of embryonic day 18 (E18) or postnatal day 2 (P2) Wistar rats, as described previously (13). Briefly, the cortices were dissociated by trypsinization and pipetting. The dissociated cells were suspended in modified Eagle's medium supplemented with 10070 fetal bovine serum and plated on uncoated 25 cm2 flasks. The culture medium was changed 24 hr after the plating and then every 3-4 days. A monolayer of type I astrocytes was obtained 10-14 days after. The primary cells were dissociated by trypsinization and reseeded on uncoated 48-well plates at a density of 10,000 cells/cm2. After the cells became confluent (5 6 days after the plating), the culture me dium was switched to serum-free medium, and experiments were initiated 24 hr later. Test reagents were added to the culture medium.
Morphological observation
Changes in cell morphology were assessed by microscopic examination. To examine expression of glial fibrillary acidic protein (GFAP), the cells were fixed with 4070 paraformaldehyde, incubated with monoclonal anti bodies to GFAP (Amersham, Little Chalfont, UK) and stained with a Vectastain ABC kit (Vector, Burlingame, CA, USA) as described in our previous paper (14). The numbers of polygonal cells and stellate cells were counted under a microscope, and the percentage of stellate cells was calculated.
Determination of cellular cyclic AMP After the cells were exposed to isoproterenol for given periods of time, the reactions were terminated by remov ing the medium and adding 150 p1 of 0.1 N perchloric acid. Cells were sonicated and then centrifuged at 15,000 X g for 10 min at 41C. The amount of cyclic AMP in the supernatant was determined by using the cyclic AMP enzyme-immunoassay system (RPN225, Amer sham) according to the manufacturer's instructions. Total number of cells in each condition was estimated by using sister cultures, and cellular cyclic AMP level was presented as fmol per cell.
Data analyses
The pD2 and pA2 values were calculated by analyzing the concentration-effect curves, according to our previous 
RESULTS
In the absence of stimulation, cultured astrocytes ob tained from either ages (E18 or P2) exhibited flattened, polygonal morphology and expressed a low level of GFAP, typical of type I astrocytes (Fig. 1) . When the ã drenoceptor agonist isoproterenol (10-6 M) was added to the culture medium, polygonal astrocytes differentiated into stellate cells, which had several long processes emanating from rounded somata and expressed a high level of GFAP (Fig. 1) . Figure 2A shows the time course of astrocyte stellation induced by 10-6 M isoproterenol. P2 astrocytes responded more rapidly than E18 astro cytes. Figure 2B shows the concentration-effect relation ship for isoproterenol-induced astrocyte stellation. nists were investigated. In both E18 and P2 astrocytes, isoproterenol-induced stellation was competitively block ed by the non-selective /3-adrenoceptor antagonist timolol (Fig. 3: A and B) and the selective (31-adrenoceptor an tagonist atenolol (Fig. 3: C and D) . The selective P2 adrenoceptor antagonist butoxamine was effective only at a high concentration (10-'M) ( isoproterenol-induced stellation were not different be tween E18 and P2 astrocytes (Table 1) . It is well-known that ,3-adrenoceptor stimulation leads to an increase in intracellular cyclic AMP levels. To exam ine if j3-adrenoceptor-mediated cyclic AMP production is different between E18 and P2 astrocytes, we directly measured cellular cyclic AMP levels. Basal cyclic AMP levels in E18 and P2 astrocyte cultures were 2.63:L0.11 fmol/cell (n = 5) and 2.48 ± 0.05 fmol/cell (n = 5), respec tively. Following addition of isoproterenol, cellular cyclic AMP level was rapidly increased and reached a peak approximately 30 min after (Fig. 4A) . The cyclic AMP response to isoproterenol was virtually the same in E18 and P2 astrocytes, in terms of both time course (Fig. 4A ) and concentration dependency (Fig. 4B) .
To examine the possibility that the mechanisms down stream from cyclic AMP production are different be tween E18 and P2 astrocytes, we investigated the effects of dibutyryl cyclic AMP (dBcAMP), a membrane-perme able cyclic AMP analog. Treatment with dBcAMP (1 mM) induced stellation in both E18 and P2 astrocytes, but the responses to dBcAMP were remarkably different between E18 and P2 astrocytes. P2 astrocytes responded to dBcAMP more rapidly than E18 astrocytes (Fig. 5A) . Effective concentration of dBcAMP in inducing stellation was much lower in P2 astrocytes than in E18 astrocytes (Fig. 5B) .
Astrocyte stellation is also induced by activation of protein kinase C (PKC) (16, 17). To examine if develop mental changes are specific for cyclic AMP-mediated events, we investigated the effects of the PKC activator phorbol 12-myristate 13-acetate (PMA) on E18 and P2 astrocytes. As shown in Fig. 6A , treatment with 50 nM PMA induced stellation in both E18 and P2 astrocytes. PMA-induced stellation occurred slowly, compared to isoproterenol or dBcAMP-induced stellation. E18 astro cytes appeared to respond to PMA better than P2 astro cytes, but the difference was not statistically significant (Fig. 6 ). 
DISCUSSION
The cellular mechanisms underlying astrocyte stellation induced by ~-adrenoceptor stimulation are currently con sidered to be as follows: Stimulation of ~-adrenoceptor leads to an increase in cellular cyclic AMP level and the activation of cyclic AMP-dependent protein kinase (PKA), which in turn produces phosphorylation of inter mediate filament proteins or depolymerization of actin, causing stellation (18-24). In the present study, we found that ~-adrenoceptor stimulation induced stellation more rapidly and potently in P2 astrocytes than in E18 astro cytes. What step of the mechanisms is different in E18 and P2 astrocytes?
In both E18 and P2 astrocytes, isoproterenol-induced stellation was blocked by timolol or atenolol more po tently than by butoxamine. The pA2 values of timolol, atenolol and butoxamine against isoproterenol-induced stellation were not different between E18 and P2 astro cytes, indicating that the response is mediated by 31 adrenoceptors in either ages. Furthermore, functions of ,3-adrenoceptors are probably the same in E18 and P2 astrocytes because isoproterenol-stimulated cyclic AMP production was similar in E18 and P2. The mechanisms downstream from cyclic AMP production are likely to be different between E18 and P2.
Treatment with dBcAMP induced stellation in P2 astro cytes more rapidly and potently than in E18 astrocytes, indicating that the sensitivity to cyclic AMP is higher in P2 astrocytes than in E18 astrocytes. Different responses of E18 and P2 astrocytes to isoproterenol are probably attributed to changes of the sensitivity to cyclic AMP.
The cytoskeleton is thought to play a major role in the determination of cell morphology. Although the molecu lar basis underlying astrocyte stellation is not fully understood, several lines of evidence suggest that protein phosphorylation is a key process regulating the assembly disassembly of cytoskeletal components. For example, phosphorylation of the N-terminal domain of the inter mediate filament vimentin by PKA or PKC induces depolymerization of the filaments (25). Phosphorylation of GFAP by PKA or PKC also results in depolymeriza tion of the filaments (26). More importantly, it has been reported that PKA and PKC phosphorylate the same sites of the intermediate filaments (21). This observation sug gests that the PKA and PKC signal transduction systems converge at the level of protein phosphorylation.
In the present study, PMA-induced stellation was similar be tween E18 and P2, indicating that PKC-mediated mecha nisms are unchanged during these developmental stages. Protein phosphorylation common to the PKA and PKC systems appears to be the same in E18 and P2. We are planning to investigate possible developmental changes in cyclic AMP-dependent protein phosphorylation in astro cytes.
What is the physiological significance of developmental changes in astrocyte reactivity? In preliminary experi ments, we observed that asrocyte stellation induced by isoproterenol or dBcAMP in E20 was similar to that in E18 (our unpublished data), implying that astrocyte reactivity increases after birth. It may be necessary for neonates to quickly adjust themselves to new circum stances. Since stellate astrocytes participate in the for mation of a neuronal network by providing neurotrophic support (4, 5) or by guiding neuronal migration (7, 8), increased reactivity of astrocytes may contribute to neural plasticity during neonatal stages.
In conclusion, we have shown that a cyclic AMP-de pendent, but not PKC-mediated, regulatory mechanism for astrocyte stellation is developed from late embryonic to neonatal stages. Further investigations are underway in our laboratory to find a key molecule regulating the sen sitivity to cyclic AMP.
